Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3577–3600 of 4,974 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Accepts healthy volunteers Clear all

Conditions: Pre-diabetes, Obesity
Interventions: Mirabegron 50 MG, Tadalafil 10 MG, Placebo; Drug
Lead sponsor: Philip Kern; Other
Eligibility: 35 Years to 65 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Smoking Cessation
Interventions: Empowering Cessation for the ACS South; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 100 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Menopause, Hot Flashes, Mood
Interventions: Shatavari extract, Shatavari + Ashwagandha extract, Placebo; Dietary Supplement
Lead sponsor: SF Research Institute, Inc.; Network
Eligibility: 45 Years to 55 Years · Female only
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity, Overweight
Interventions: Eloralintide, Combined oral contraceptive; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Daytona Beach, Florida • Dallas, Texas

Conditions: Oxygen Saturation
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Ureteral Stone
Interventions: Ureteroscopy; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2030
U.S. locations: 2
States / cities: San Francisco, California • Aurora, Colorado

Conditions: Skin Cancer
Interventions: Ultraviolet B Radiation, No Ultraviolet B Radiation; Radiation · Other
Lead sponsor: Wright State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Fairborn, Ohio

Conditions: Pain Control, Anxiety, Memory
Interventions: Pain Threat Manipulation, Pain Controllability Manipulation; Behavioral
Lead sponsor: Trustees of Dartmouth College; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Hanover, New Hampshire

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Educational Cancer Intervention, ICF Text Version 1, ICF Text Version 2, ICF Video Version 1, ICF Video Version 2, ICF Video Version 3, ICF Video Version 4, Survey Administration; Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Social Connectedness, Peace of Mind, Stress
Interventions: Mindfulness practice with Tao Art (Calligraphy and Song Love Peace and Harmony).; Other
Lead sponsor: Sha Research Foundation; Other
Eligibility: 19 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: ARDS (Acute Respiratory Distress Syndrome)
Interventions: HT31-1, Saline (0.9%, sterile, for infusion); Drug · Other
Lead sponsor: HTIC, Inc; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Athletic Injuries, Sport Injuries
Interventions: Community Resiliency Model (CRM), Control; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Antibiotic Prophylaxis
Interventions: Nitrofurantoin; Drug
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Malignant Brain Neoplasm, Malignant Solid Neoplasm, Multiple Sclerosis, Neuroendocrine Tumor, Prostate Carcinoma
Interventions: Biospecimen Collection, Exercise Intervention, Magnetic Resonance Imaging, Questionnaire Administration, Respiratory Therapy; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Insulin Resistance, Mild Cognitive Impairment, Cognitive Decline, Neurodegenerative Disorders
Interventions: Sabroxy®, Placebo; Dietary Supplement · Other
Lead sponsor: SF Research Institute, Inc.; Network
Eligibility: 40 Years to 80 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alzheimer Disease, Dementia
Interventions: Care Partner Hospital Assessment Tool; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Obesity, Morbid, NASH - Nonalcoholic Steatohepatitis, Chronic Inflammation
Interventions: Bariatric surgery; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Small-cell Lung Cancer
Interventions: Proton-beam Therapy for Small Cell Lung Cancer; Radiation
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: HIV, Substance Use Disorders, Substance Use, AIDS
Interventions: CC PrTNER; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 15 Years to 29 Years · Male only
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland • Philadelphia, Pennsylvania

Conditions: Cancer, Cancer , Healthy
Interventions: Standard-PN, 4R-PN, AI-PN; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Fentanyl Overdose, Fentanyl Poisoning
Interventions: Naloxone Hydrochloride, Fentanyl, Sterile Saline, CS-1103; Drug
Lead sponsor: Clear Scientific, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Glendale, California

Conditions: Cognitive Change
Interventions: Nongamified N-back training, Gamified N-back training, Multiple Domain Training, Coaching Session; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 780 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Disparities, Community Health Workers, Cardiovascular Diseases, Social Determinants of Health (SDOH)
Interventions: DECIDE, Community Health Worker Support; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 35 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Health Behavior
Interventions: Added sugar warning, Control label; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 543 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

Empowering Cessation ACS South Region

Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study

A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight

Nellcor™ Investigational Device Sitting-Walking Study

UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones

DNA Repair Activity in the Skin of Day and Night Shift Workers

Virtual Contexts for Affective Modulation

Community Enhanced Virtual Informed Consent

The Effects of Mindfulness Practice With Tao Art (Love Peace Harmony Calligraphy and Song) on Well-being

Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS

Rise With Resilience

Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

Dementia Care Partner Hospital Assessment Tool

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

The Collaborative Care PrTNER Study

Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

Executive Function Training for Children and Adolescents

Philly CEAL- DECIDE+ Adaptation

Sugary Drink Labeling Study